The General Pharmaceutical Council (GPhC) has launched a consultation on proposals to introduce revalidation for pharmacy professionals. This is an important change to what pharmacists and [...]
GSK has announced the next phase of Tackle Meningitis, an awareness campaign in schools and sports clubs across the UK, in partnership with Former England rugby player, Matt Dawson. Schools and [...]
Global pharmaceutical company, Mylan, has announced the US launch of Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg, a generic version of the reference listed drug, Trilafon Tablets 2 mg, 4 [...]
Well has announced a long-term partnership with Keele University, to further enhance learning and professional development opportunities for those studying at its School of Pharmacy. Earlier this [...]
Aspirin use may not provide cardiovascular benefits for patients who have peripheral vascular disease, an analysis by University of Florida Health researchers has found. Aspirin therapy has been [...]
The US Food and Drug Administration (FDA) has approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition. [...]
Reacting to the news that two pharmacists have been injured in a stabbing incident in a community pharmacy in West Belfast this morning, Sheelin McKeagney, Chair of the Pharmacy Forum NI, said: [...]
Pfizer has confirmed that the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has launched a public consultation on the reclassification of sildenafil 50mg to [...]
The Care Quality Commission (CQC) has taken further action to protect people in England who are using websites to obtain prescription medicines. The quality regulator has published inspection [...]
In a new snapshot survey of leading pharmaceutical businesses in the UK, companies have said that changes to the way the National Institute for Health & Care Excellence (NICE) and NHS England [...]
